# Phototoxicity Potential of 6% Bemotrizinol

> **NCT05254925** · PHASE2 · COMPLETED · sponsor: **dsm-firmenich Switzerland AG** · enrollment: 34 (actual)

## Conditions studied

- Phototoxic Response

## Interventions

- **DRUG:** Sunscreen oil with 6% Bemotrizinol
- **OTHER:** Sunscreen oil vehicle
- **DRUG:** Dispersion of 6% BEMT in petrolatum
- **OTHER:** Petrolatum vehicle

## Key facts

- **NCT ID:** NCT05254925
- **Lead sponsor:** dsm-firmenich Switzerland AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-28
- **Primary completion:** 2022-03-03
- **Final completion:** 2022-04-03
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05254925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05254925, "Phototoxicity Potential of 6% Bemotrizinol". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05254925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*